During the past decade, Bioserve Clinical Research Private Limited conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Bioserve Clinical Research Private Limited" are "Healthy" (24 trials). Many other conditions were trialed in "Bioserve Clinical Research Private Limited" in a lesser frequency.

Most popular intervention types in "Bioserve Clinical Research Private Limited" are "Drug" (24 trials). Other intervention types were less common.

The name of intervention was led by "Divalproex Sodium" (5 trials), "Lamotrigine" (4 trials), "Aricept" (2 trials), "Donepezil Hydrochloride" (2 trials) and "Metoprolol Succinate" (2 trials). Other intervention names were less common.

The vast majority of trials in "Bioserve Clinical Research Private Limited" are 13 trials for "All" genders and 9 trials for "Male" genders.

Currently, there are NaN active trials in "Bioserve Clinical Research Private Limited". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Bioserve Clinical Research Private Limited, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Bioserve Clinical Research Private Limited, 24 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".